By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

BeiGene Co.,Ltd 

No.30 Science Park Road
Zhong-Guan-Cun Life Science Park
Changping District  Beijing    China
Phone: n/a Fax: n/a


SEARCH JOBS

BeiGene is a globally focused biopharmaceutical company dedicated to becoming a leader in the discovery and development of innovative, molecularly targeted and immuno-oncology drugs for the treatment of cancer.

YEAR FOUNDED:

October 28, 2010

LEADERSHIP:

Founders: Xiaodong Wang, and John Oyler

CEO: John Oyler

CFO: Howard Liang

CMO (Medical): Eric Hedrick

JOBS:

Please click here for BeiGene job opportunities.

CLINICAL TRIAL:

Please click here for clinical trial information.


Key Statistics


Email:
Ownership: Public

Web Site: BeiGene
Employees:
Symbol: BGNE
 



Industry
Pharmaceutical






Company News
BeiGene (BGNE) And Cancer Genetics (CGIX) Form Precision Medicine Collaboration 12/8/2016 9:25:08 AM
Week In Review: Beijing's BeiGene (BGNE) Raises $185 Million For Clinical Trial Program 11/28/2016 10:46:44 AM
Beijing's BeiGene (BGNE) Raises $200 Million In A Secondary Offering 11/23/2016 9:26:30 AM
BeiGene (BGNE) Files To Raise $150 Million In Secondary Offering 11/14/2016 9:56:46 AM
BeiGene (BGNE) Approved To Start China Trial Of PD-1 Drug 9/13/2016 8:35:16 AM
Medivation (MDVN) Exec Jumps Ship to Become CMO at BeiGene (BGNE) 8/25/2016 6:52:40 AM
BeiGene (BGNE) OK'd To Test PARP Inhibitor In China 8/19/2016 10:14:43 AM
China's BeiGene (BGNE) Starts Combination Trial For Two Novel Cancer Drugs 7/7/2016 9:09:18 AM
BeiGene Presents Positive Interim Data From Trial Of RAF-Inhibitor 4/19/2016 12:15:39 PM
BeiGene Announces Presentations On BGB-283 And Other Pipeline Agents At The 2016 AACR Annual Meeting 3/17/2016 8:07:15 AM
123456
//-->